本文選題：胃腸道間質(zhì)瘤 + 回顧性研究��； 參考：《蘭州大學(xué)》2017年碩士論文

【摘要】：目的:通過對(duì)胃腸道間質(zhì)瘤的臨床特點(diǎn)、組織學(xué)類型、手術(shù)方式、診治經(jīng)驗(yàn)等進(jìn)行回顧性研究,以提高胃腸道間質(zhì)瘤的認(rèn)識(shí)及診治水平。方法:回顧性分析我院收治的行手術(shù)治療的32例胃腸道間質(zhì)瘤病人的臨床資料,同時(shí)結(jié)合納入的89篇文獻(xiàn),對(duì)其臨床特點(diǎn)、病理、診斷、治療以及預(yù)后等進(jìn)行統(tǒng)計(jì)學(xué)描述,并分析整理相關(guān)臨床資料。結(jié)果:32名患者中,19名女性患者,13名男性患者,女:男=1.46:1,年齡:19-83歲,平均:(56.00±14.438)歲,所有患者術(shù)后均經(jīng)病理及免疫組化CD117及CD34確診。32例GISTs原發(fā)部位:27例原發(fā)胃部,2例在小腸,3例原發(fā)胃腸道外(1例原發(fā)小網(wǎng)膜,1例原發(fā)小腸系膜,1例原發(fā)部位在腹膜后);組織類型中:梭形、混合細(xì)胞型分別為30例、2例;腫瘤直徑:2-15cm,平均:(5.94±3.441)cm,5cm:16例,5-10cm:13例,10cm:3例;腫瘤性壞死:9例;極低危險(xiǎn)度1例,低危11例,中危9例,高危11例;25例出現(xiàn)腹部不適,14例出現(xiàn)嘔血、黑便,1例腹部捫診到包塊,1例行體格檢查時(shí)發(fā)現(xiàn);輔助檢查:32例行CT檢查,18例行胃鏡檢查,16例行超聲內(nèi)鏡檢查。實(shí)驗(yàn)室檢測(cè):10例潛血試驗(yàn)陽性,9例血紅蛋白下降,2例白蛋白下降,10例腫瘤標(biāo)志物升高。對(duì)25例病患進(jìn)行了術(shù)中出血量的統(tǒng)計(jì),出血量:10-800ml,平均:(139.60±177.752)ml。腫瘤大小、核分裂數(shù)多少、腫瘤不同原發(fā)部位及Ki67指數(shù)不同在腫瘤危險(xiǎn)度分級(jí)比較中具有統(tǒng)計(jì)學(xué)意義(P0.05)。手術(shù)方式不同在術(shù)后住院時(shí)間的比較中不具有統(tǒng)計(jì)學(xué)意義(P0.05)。CD117檢測(cè):31例陽性(96.9%),1例陰性(3.1%);CD34檢測(cè):28例陽性(87.5%),4例陰性(12.5%);DOG1檢測(cè):4例陰性(12.5%),28例陽性(87.5%)。納入89篇文獻(xiàn)報(bào)道4737例患者,男:女=1.10:1,就診時(shí)間1985年4月-2016年3月,年齡:15-87歲。GISTs原發(fā)部位:食管所占百分比(1.1%),胃所占百分比(71.9%),小腸所占百分比(19.8%),結(jié)直腸所占百分比(3.5%),胃腸道外百分比(3.6%)。4737例患者均經(jīng)病理檢查診斷為間質(zhì)瘤。結(jié)論:早期發(fā)現(xiàn)胃腸道間質(zhì)瘤相對(duì)困難,完整的手術(shù)切除仍是目前最佳的治療手段,對(duì)于中、高危人群,應(yīng)同時(shí)輔以分子靶向藥物治療。
[Abstract]:Objective: to improve the understanding and diagnosis of gastrointestinal stromal tumors (GIST) by retrospective study of clinical features, histological types, surgical methods, diagnosis and treatment experience.Methods: the clinical data of 32 patients with gastrointestinal stromal tumors treated by surgery in our hospital were analyzed retrospectively. The clinical features, pathology, diagnosis, treatment and prognosis were analyzed statistically.The clinical data were analyzed and analyzed.Results of the 32 patients, 19 were female and 13 were male. Female: male 1.46: 1, age: 19 to 83, average age: 56.00 鹵14.438.All patients were diagnosed by pathological and immunohistochemical CD117 and CD34. 32 cases of GISTs were diagnosed as primary site: 27 cases of primary gastric carcinoma 2 cases of primary stomach in 3 cases of primary gastrointestinal tract and 1 case of primary omentum omentum in 1 case of primary mesentery of small intestine in the peritoneum of 1 case.In the type of tissue: fusiform,There were 30 cases of mixed cell type, 2 cases of mixed cell type, 2 cases of tumor diameter: 2-15 cm, mean diameter of 5: 94 鹵3.441 cm + 5 cm%, 16 cases of 5-10 cm: 13 cases, 13 cases of tumor necrosis, 9 cases of tumor necrosis, 1 case of very low risk, 11 cases of low risk, 9 cases of moderate risk, 14 cases of abdominal discomfort, 14 cases of high risk, 14 cases of abdominal discomfort, 14 cases of high risk.In 1 case with black stool, 1 case with abdominal palpation was diagnosed as mass, 1 case was found with physical examination, 32 cases with CT examination, 18 cases with gastroscopy and 16 cases with endoscopic ultrasonography.In the laboratory, 10 cases of occult blood test were detected. 9 cases of hemoglobin decreased and 2 cases of albumin decreased. 10 cases of tumor markers were elevated.The intraoperative bleeding volume of 25 patients was estimated to be 10 ~ (-800) ml, with an average of 139.60 鹵177.752 ml 路min ~ (-1).The size of the tumor, the number of mitotic cells, the different primary sites of the tumor and the Ki67 index were statistically significant in the comparison of tumor risk grade (P 0.05).There was no statistical significance in the comparison of postoperative hospitalization time between the two groups. There was no statistical significance in the comparison of postoperative hospitalization time. There were 31 cases with positive rate of 96. 9% and 1 case with negative rate of 3. 1%. CD34 was detected in 8: 28 cases with positive rate of 87.5% and 4 cases with negative 12. 5% DOG 1. In 4 cases, there were 12. 528 cases with negative 12. 5% and 12. 5% with positive value of 87.55.The results showed that there was no significant difference between the two groups (P 0. 05, P < 0. 05).A total of 4737 patients (male: female 1.10: 1) were included in 89 literature reports. The time of consultation was April 1985-March 2016.Age 15-87 years old. GISTs primary site: the percentage of esophagus is 1.1%, the percentage of stomach is 71.9%, the percentage of small intestine is 19.881%, the percentage of colon and rectum is 3.55.The percentage of gastrointestinal tract is 3.60.4737 cases are diagnosed as stromal tumors by pathological examination.Conclusion: early detection of gastrointestinal stromal tumors is relatively difficult, complete surgical resection is still the best treatment, for middle and high risk population, should be supplemented with molecular targeted drug treatment.
【學(xué)位授予單位】：蘭州大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R735

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 雷嘉;胃腸道間質(zhì)瘤20例病理分析[J];河北醫(yī)藥;2001年06期

2 張德昌,王志純,艾書躍,李世紅,李士建,劉玉龍;胃腸道間質(zhì)瘤(附2例報(bào)告)[J];臨床腫瘤學(xué)雜志;2001年04期

3 許海鶯,陳宏穎;胃腸道間質(zhì)瘤20例臨床病理分析[J];齊齊哈爾醫(yī)學(xué)院學(xué)報(bào);2001年01期

4 沈玉林,郭春君;胃腸道間質(zhì)瘤13例臨床病理分析[J];四川腫瘤防治;2001年03期

5 黃志勇,章宜芬,王寧,張華勇;胃腸道間質(zhì)瘤的研究進(jìn)展[J];腫瘤學(xué)雜志;2001年04期

6 盧俊,吳亞光,蘇忠學(xué),穆慶嶺,吳太璜;胃腸道間質(zhì)瘤的診斷和治療[J];山東醫(yī)藥;2002年19期

7 李學(xué)民,何政,馬占明;胃腸道間質(zhì)瘤的診治[J];邯鄲醫(yī)學(xué)高等�？茖W(xué)校學(xué)報(bào);2002年01期

8 石書紅 ,梁輝 ,俞學(xué)明;胃腸道間質(zhì)瘤42例臨床分析[J];交通醫(yī)學(xué);2002年03期

9 熊小亮;胃腸道間質(zhì)瘤研究進(jìn)展[J];江西醫(yī)藥;2002年01期

10 于志強(qiáng),朱立元,王有德;胃腸道間質(zhì)瘤的臨床分析[J];中華胃腸外科雜志;2002年01期

相關(guān)會(huì)議論文 前10條

1 于吉人;萬凱明;李甫強(qiáng);劉小孫;楊偉歷;;184例胃腸道間質(zhì)瘤的臨床病理和免疫組化研究[A];2009年浙江省外科學(xué)學(xué)術(shù)年會(huì)論文匯編[C];2009年

2 張威;葉再元;邵欽樹;王躍東;許曉東;趙仲生;;胃腸道間質(zhì)瘤的臨床研究[A];2009年浙江省外科學(xué)學(xué)術(shù)年會(huì)論文匯編[C];2009年

3 劉良進(jìn);畢俊英;;多層螺旋CT診斷胃腸道間質(zhì)瘤17例分析[A];湖北省抗癌協(xié)會(huì)腫瘤影像專業(yè)委員會(huì)成立暨第一屆學(xué)術(shù)大會(huì)論文匯編[C];2009年

4 竺楊文;王躍東;李保軍;;胃腸道間質(zhì)瘤的腹腔鏡外科治療[A];2004年浙江省外科學(xué)學(xué)術(shù)年會(huì)論文匯編[C];2004年

5 韓少良;周宏眾;余作黔;程駿;陳哲京;姚建高;朱冠保;;胃腸道間質(zhì)瘤的臨床病理特點(diǎn)與外科治療[A];2005年浙江省外科學(xué)術(shù)會(huì)議論文匯編[C];2005年

6 楊景林;;胃腸道間質(zhì)瘤的新概念及研究進(jìn)展[A];2006年貴州省醫(yī)學(xué)會(huì)消化及內(nèi)鏡學(xué)分會(huì)學(xué)術(shù)大會(huì)論文匯編[C];2006年

7 劉變英;王穎;李小會(huì);楊嫦娥;王文英;;胃腸道間質(zhì)瘤的診斷和微創(chuàng)治療研究[A];第十七屆中國(guó)內(nèi)鏡醫(yī)師大會(huì)論文集[C];2007年

8 胡鳳玲;許國(guó)強(qiáng);;胃腸道間質(zhì)瘤臨床分析[A];浙江省中西醫(yī)結(jié)合學(xué)會(huì)消化專業(yè)第八次學(xué)術(shù)年會(huì)暨省中西醫(yī)結(jié)合消化系疾病新進(jìn)展學(xué)習(xí)班論文匯編[C];2007年

9 鄭志強(qiáng);;胃腸道間質(zhì)瘤患者預(yù)后多因素分析[A];2008年浙江省外科學(xué)術(shù)年會(huì)論文匯編[C];2008年

10 伍小軍;方m錁，

本文編號(hào)：1752604